Delem A - Search Results

1

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Among authors: delem a. Vaccine. 1997 Nov;15(16):1732-6. doi: 10.1016/s0264-410x(97)00118-7. Vaccine. 1997. PMID: 9364675 Clinical Trial.

2

Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A.

Delem A, Safary A, De Namur F, Hauser P, D'Hondt E. Delem A, et al. Vaccine. 1993;11(4):479-84. doi: 10.1016/0264-410x(93)90291-5. Vaccine. 1993. PMID: 8385844 Clinical Trial.

3

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

Leroux-Roels G, Desombere I, De Tollenaere G, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Among authors: delem a. Vaccine. 1997 Nov;15(16):1724-31. doi: 10.1016/s0264-410x(97)00117-5. Vaccine. 1997. PMID: 9364674 Clinical Trial.

4

Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.

Goubau P, Van Gerven V, Safary A, Delem A, Knops J, D'Hondt E, André FE, Desmyter J. Goubau P, et al. Among authors: delem a. Vaccine. 1992;10 Suppl 1:S114-8. doi: 10.1016/0264-410x(92)90561-w. Vaccine. 1992. PMID: 1335638 Clinical Trial.

5

Persistence of vaccine-induced antibody to hepatitis A virus.

Wiedermann G, Ambrosch F, André FE, D'Hondt E, Delem A, Safary A. Wiedermann G, et al. Among authors: delem a. Vaccine. 1992;10 Suppl 1:S129-31. doi: 10.1016/0264-410x(92)90566-3. Vaccine. 1992. PMID: 1335643 Clinical Trial.

6

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.

André FE, D'Hondt E, Delem A, Safary A. André FE, et al. Among authors: delem a. Vaccine. 1992;10 Suppl 1:S160-8. doi: 10.1016/0264-410x(92)90576-6. Vaccine. 1992. PMID: 1335652 Review.

7

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.

Wiedermann G, Ambrosch F, Kollaritsch H, Hofmann H, Kunz C, D'Hondt E, Delem A, André FE, Safary A, Stéphenne J. Wiedermann G, et al. Among authors: delem a. Vaccine. 1990 Dec;8(6):581-4. doi: 10.1016/0264-410x(90)90013-c. Vaccine. 1990. PMID: 1965077 Clinical Trial.

8

Inactivated hepatitis A vaccine: long-term antibody persistence.

Wiedermann G, Kundi M, Ambrosch F, Safary A, D'Hondt E, Delem A. Wiedermann G, et al. Among authors: delem a. Vaccine. 1997 Apr-May;15(6-7):612-5. doi: 10.1016/s0264-410x(96)00242-3. Vaccine. 1997. PMID: 9178459 Clinical Trial.

9

Simultaneous vaccination against hepatitis A and B: results of a controlled study.

Ambrosch F, André FE, Delem A, D'Hondt E, Jonas S, Kunz C, Safary A, Wiedermann G. Ambrosch F, et al. Among authors: delem a. Vaccine. 1992;10 Suppl 1:S142-5. doi: 10.1016/0264-410x(92)90570-a. Vaccine. 1992. PMID: 1335647 Clinical Trial.

10

Thermostability of an inactivated hepatitis A vaccine stored at 37 degrees C for one week.

Wiedermann G, Ambrosch F, André FE, Delem A, D'Hondt E, Safary A. Wiedermann G, et al. Among authors: delem a. J Med Virol. 1994 Dec;44(4):442. doi: 10.1002/jmv.1890440423. J Med Virol. 1994. PMID: 7897377 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters